Yuka Tanji

Phase 2 randomized placebo‐controlled study of lasmiditan for the acute treatment of migraine in Japanese patients

Fumihiko Sakai, Takao Takeshima, Gosuke Homma et al. · Headache The Journal of Head and Face Pain · 2021 · 47 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Long-term treatment with lasmiditan in patients with migraine: post hoc analysis of treatment patterns and outcomes from the open-label extension of the CENTURION randomized trial

Mika Komori, Akichika Ozeki, Yuka Tanji et al. · The Journal of Headache and Pain · 2024 · 26 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Perceptions and impact of bipolar disorder in Japan: results of an Internet survey

Koichiro Watanabe, Eiji Harada, Takeshi Inoue et al. · Neuropsychiatric Disease and Treatment · 2016 · 20 citations · Full text

Medicine, Health Sciences, Psychiatry +17

Galcanezumab Efficacy Through the Dosing Interval in Japanese Patients with Episodic Migraine: Post Hoc Analysis of a Phase 2 Randomized Trial

Mamoru Shibata, Atsuko Nihira, Yuka Tanji et al. · Neurology and Therapy · 2023 · 18 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Lasmiditan in Japanese Patients with Common Migraine Comorbidities or Concomitant Medications: A Post Hoc Safety and Efficacy Analysis from the MONONOFU Study

Shigekazu Kitamura, Noboru Imai, Yuka Tanji et al. · Journal of Pain Research · 2023 · 12 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17